HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach aims to cut side effects in head and neck cancer
Disease control Not yet recruitingThis study tests a shorter course of radiation (hypofractionated radiotherapy) for people with intermediate-risk head and neck cancer who have had surgery. The goal is to see if this approach is safe and effective at controlling the cancer while reducing long-term side effects. A…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Apr 29, 2026 01:36 UTC
-
New drug cocktail shows promise in battle against head and neck cancer
Disease control Not yet recruitingThis study tests whether combining the immunotherapy drug camrelizumab with either an EGFR antibody or chemotherapy can help people with advanced head and neck cancer live longer. About 246 adults with stage III or IV cancer will receive the treatment before and after surgery. Th…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Yue He, MD • Aim: Disease control
Last updated Apr 29, 2026 01:36 UTC
-
New drug cocktail aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis study tests whether giving a new drug (becotatug vedotin) alone or with immunotherapy before surgery can help shrink advanced head and neck cancer. About 120 adults with resectable tumors will receive the treatment and then have surgery. The main goal is to see if the cancer…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Apr 29, 2026 01:35 UTC
-
Glow-in-the-dark dye could help surgeons spot hidden cancer cells
Diagnosis Not yet recruitingThis early-phase trial tests a fluorescent dye called ABY-029 that makes cancer cells glow during surgery. The goal is to find the right dose so surgeons can better see and remove head and neck tumors. About 24 adults with operable head and neck cancer will receive a tiny amount …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Diagnosis
Last updated Apr 29, 2026 01:36 UTC